PLUR

#4490
Pluri Inc. Common Stock
3.4000 USD
+1.78%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
3.3300
3.4000
Faixa anual
3.0100
3.8220
Mudança diária
+1.78%
Mudança mensal
+2.56%
Mudança em 6 meses
-11.04%
Mudança anual
-11.04%
Fechamento anterior
3.3407
Abrir
3.3300
Bid
Ask
Mínimo
3.3300
High
3.4000
Volume
7
Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas
Trimestral Ano
  • Market Capitalization 34.1725 M
  • Employee 142
  • Founded 2001
  • CEO Yaky Yanay
  • Website www.pluri-biotech.com
  • Headquarter Nevada, United States
  • FIGI BBG000DQX509
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.39
Price to sales ratio
23.48

Pluri Inc

Pluri Inc., formerly Pluristem Therapeutics, is an Israeli company engaged in the development of human placental adherent stromal cells for commercial use in disease treatment. According to the company's website, it extracts adult stem cells exclusively from postnatal placentas.

Notícias